A novel social fear conditioning procedure alters social behavior and mTOR signaling in differentially housed adolescent rats.

animal escape reaction models post-traumatic prefrontal cortex ribosomal protein S6 social behavior social isolation stress disorders

Journal

Developmental psychobiology
ISSN: 1098-2302
Titre abrégé: Dev Psychobiol
Pays: United States
ID NLM: 0164074

Informations de publication

Date de publication:
01 2021
Historique:
received: 12 11 2019
revised: 07 04 2020
accepted: 30 04 2020
pubmed: 12 6 2020
medline: 15 12 2021
entrez: 12 6 2020
Statut: ppublish

Résumé

Vulnerabilities to fear-related disorders can be enhanced following early life adversity. This study sought to determine whether post-weaning social isolation (PSI), an animal model of early life adversity, alters the development of social fear in an innovative model of conditioned social fear. Male and female Sprague-Dawley rats underwent either social rearing (SR) or PSI for 4 weeks following weaning. Rats were then assigned to groups consisting of either Footshock only, Social conditioned stimulus (CS) only, or Paired footshock with a social CS. Social behavior was assessed the next day. We observed a novel behavioral response in PSI rats, running in circles, that was rarely observed in SR rats; moreover, this behavior was augmented after Paired treatment in PSI rats. Other social behaviors were altered by both PSI and Paired footshock and social CS. The mammalian target of rapamycin (mTOR) pathway was assessed using immunohistochemistry for phosphorylated ribosomal protein S6 (pS6) in subregions of the prefrontal cortex (PFC) and amygdala. Paired treatment produced opposite effects in the PFC and amygdala in males, but no differences were observed in females. Conditioned social fear produced alterations in social behavior and the mTOR pathway that are dependent upon rearing condition and sex.

Identifiants

pubmed: 32524583
doi: 10.1002/dev.22001
pmc: PMC7726006
mid: NIHMS1614304
doi:

Substances chimiques

mTOR protein, rat EC 2.7.1.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

74-87

Subventions

Organisme : NIMH NIH HHS
ID : R15 MH102717
Pays : United States

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Front Psychiatry. 2014 Jul 21;5:88
pubmed: 25101010
Behav Brain Res. 1993 Dec 20;58(1-2):69-79
pubmed: 8136051
J Comp Physiol Psychol. 1975 Dec;89(10):1204-9
pubmed: 1238435
Physiol Behav. 1987;41(2):99-102
pubmed: 3685168
Neurosci Biobehav Rev. 2008 Aug;32(6):1087-102
pubmed: 18423591
Behav Brain Res. 2001 May;120(2):221-4
pubmed: 11182170
Cell Tissue Res. 2013 Oct;354(1):107-18
pubmed: 23760888
Neuropsychopharmacology. 2012 May;37(6):1433-43
pubmed: 22237310
Behav Brain Res. 2015 Jun 1;286:249-55
pubmed: 25746455
J Biol Chem. 2008 Feb 1;283(5):2631-43
pubmed: 18057005
Int J Mol Sci. 2019 Oct 15;20(20):
pubmed: 31618823
Toxicol Appl Pharmacol. 1965 Sep;7(5):737-45
pubmed: 4286670
Experientia. 1985 Mar 15;41(3):329-31
pubmed: 4038662
J Neurosci. 2017 Mar 1;37(9):2463-2470
pubmed: 28148725
Behav Brain Res. 1982 Sep;6(1):93-100
pubmed: 7126327
Neuroscience. 2016 Jul 22;328:157-64
pubmed: 27155146
Horm Behav. 2011 Jun;60(1):28-36
pubmed: 21316368
Behav Brain Res. 2017 Jan 15;317:1-15
pubmed: 27633556
Neuroscience. 2010 Jun 30;168(2):371-86
pubmed: 20394803
CNS Neurosci Ther. 2018 Nov;24(11):1053-1062
pubmed: 29368421
Neuron. 2007 Oct 4;56(1):19-32
pubmed: 17920012
Neurobiol Dis. 2018 Mar;111:91-101
pubmed: 29274432
Neuropharmacology. 2015 Oct;97:149-59
pubmed: 26044636
Mol Psychiatry. 2017 Jan;22(1):24-36
pubmed: 27752080
Neuron. 1996 Feb;16(2):237-40
pubmed: 8789938
Science. 2011 Dec 9;334(6061):1427-30
pubmed: 22158823
Alcohol Res Health. 2000;24(2):115-23
pubmed: 11199278
Dev Psychobiol. 1977 Mar;10(2):123-32
pubmed: 838157
Psychol Med. 1999 Jul;29(4):813-21
pubmed: 10473308
Learn Mem. 2015 Nov 16;22(12):577-83
pubmed: 26572647
Neuropsychopharmacology. 2011 Jan;36(2):529-38
pubmed: 20962768
Neuropsychopharmacology. 2017 Jan;42(2):397-407
pubmed: 27577601
Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):163-78
pubmed: 12732232
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1173-7
pubmed: 19563853
Psychopharmacology (Berl). 2015 Apr;232(8):1441-50
pubmed: 25345734
Neuron. 2012 Feb 23;73(4):653-76
pubmed: 22365542
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
Brain Res Bull. 1999 Sep 1;50(1):33-9
pubmed: 10507469
Neurobiol Stress. 2015 Jan 1;1:12-22
pubmed: 25506602
Curr Top Behav Neurosci. 2016;27:171-95
pubmed: 26643998
Neurobiol Learn Mem. 2009 Mar;91(3):323-32
pubmed: 19073269
Pharmacol Biochem Behav. 1996 Apr;53(4):965-70
pubmed: 8801604
Anim Behav. 1999 Sep;58(3):563-586
pubmed: 10479372
Front Behav Neurosci. 2015 Nov 09;9:298
pubmed: 26617500
Psychopharmacology (Berl). 2014 Aug;231(15):3041-53
pubmed: 24553577
J Affect Disord. 2017 Jan 01;207:181-187
pubmed: 27723542
J Consult Clin Psychol. 2007 Apr;75(2):316-24
pubmed: 17469889
Psychon Bull Rev. 1994 Dec;1(4):429-38
pubmed: 24203551
Behav Brain Res. 2018 Apr 2;341:146-153
pubmed: 29292159
Behav Neurosci. 2008 Aug;122(4):849-54
pubmed: 18729638
Elife. 2015 Nov 14;4:
pubmed: 26568307
J Clin Child Adolesc Psychol. 2019 Mar-Apr;48(2):316-331
pubmed: 28318338
Eur J Neurosci. 2007 Oct;26(8):2315-26
pubmed: 17927774
Am J Psychiatry. 2007 Oct;164(10):1476-88
pubmed: 17898336
Neuroimage. 2011 Jun 1;56(3):881-9
pubmed: 21356318
Brain Res. 2009 Mar 31;1263:33-42
pubmed: 19368822
J Neurosci. 2019 May 22;39(21):4133-4141
pubmed: 30910790
Behav Brain Res. 2007 Jun 18;180(2):174-82
pubmed: 17477981
Cereb Cortex. 2015 Apr;25(4):895-903
pubmed: 24108802
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1765-1769
pubmed: 30635411
Neuroscience. 2004;125(1):1-6
pubmed: 15051139
Annu Rev Neurosci. 2000;23:155-84
pubmed: 10845062
Mol Cell Biol. 1997 Sep;17(9):5426-36
pubmed: 9271419
J Neurosci Res. 2017 Jan 2;95(1-2):763-776
pubmed: 27870445
Neuroscience. 2016 May 3;321:197-209
pubmed: 26204817
Behav Brain Res. 1996 Feb;75(1-2):27-32
pubmed: 8800657
Eur Neuropsychopharmacol. 2017 Sep;27(9):900-912
pubmed: 28647452
Am J Psychiatry. 2016 Nov 1;173(11):1083-1093
pubmed: 27609244
Braz J Med Biol Res. 2005 Nov;38(11):1691-6
pubmed: 16258640
Behav Brain Res. 2012 Mar 1;228(1):211-8
pubmed: 22189656
J Neurosci. 2015 Sep 2;35(35):12152-61
pubmed: 26338326
Lancet. 2013 May 11;381(9878):1683-5
pubmed: 23583019
Physiol Behav. 2012 Oct 10;107(3):440-50
pubmed: 22982514

Auteurs

Lamya'a M Dawud (LM)

Department of Integrative Biology, University of Colorado Denver, Denver, CO, USA.

Esteban C Loetz (EC)

Department of Psychology, University of Colorado Denver, Denver, CO, USA.

Brian Lloyd (B)

Department of Pharmacology, University of Colorado Anschutz Medical School, Aurora, CO, USA.

Rachel Beam (R)

Department of Integrative Biology, University of Colorado Denver, Denver, CO, USA.

Simon Tran (S)

Department of Integrative Biology, University of Colorado Denver, Denver, CO, USA.

Kim Cowie (K)

Department of Neuroscience, Children's Hospital Colorado, Aurora, CO, USA.

Kim Browne (K)

Department of Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.

Tassawwar Khan (T)

Department of Integrative Biology, University of Colorado Denver, Denver, CO, USA.

Richard Montoya (R)

Department of Psychology, University of Colorado Denver, Denver, CO, USA.

Benjamin N Greenwood (BN)

Department of Psychology, University of Colorado Denver, Denver, CO, USA.

Sondra T Bland (ST)

Department of Psychology, University of Colorado Denver, Denver, CO, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH